个性化文献订阅>期刊> Journal of Medicinal Chemistry
 

Novel Dual-Targeting Benzimidazole Urea Inhibitors of DNA Gyrase and Topoisomerase IV Possessing Potent Antibacterial Activity: Intelligent Design and Evolution through the Judicious Use of Structure-Guided Design and Structure-Activity Relationships.

  作者 Charifson, Paul S.;Grillot, Anne-Laure;Grossman, Trudy H.;Parsons, Jonathan D.;Badia, Michael;Bellon, Steve;Deininger, David D.;Drumm, Joseph E.;Gross, Christian H.;LeTiran, Arnaud;Liao, Yusheng;Mani, Nagraj;Nicolau, David P.;Perola, Emanuele;Ronkin, Stev  
  选自 期刊  Journal of Medicinal Chemistry;  卷期  2008年51-17;  页码  5243-5263  
  关联知识点  
 

[摘要]The discovery of new antibacterial agents with novel mechanisms of action is necessary to overcome the problem of bacterial resistance that affects all currently used classes of antibiotics. Bacterial DNA gyrase and topoisomerase IV are well-characterized clin. validated targets of the fluoroquinolone antibiotics which exert their antibacterial activity through inhibition of the catalytic subunits. Inhibition of these targets through interaction with their ATP sites has been less clin. successful. The discovery and characterization of a new class of low mol. wt., synthetic inhibitors of gyrase and topoisomerase IV that bind to the ATP sites are presented. The benzimidazole ureas are dual targeting inhibitors of both enzymes and possess potent antibacterial activity against a wide spectrum of relevant pathogens responsible for hospital- and community-acquired infections. The discovery and optimization of this novel class of antibacterials by the use of structure-guided design, modeling, and structure-activity relationships are described. Data are presented for enzyme inhibition, antibacterial activity, and in vivo efficacy by oral and i.v. administration in two rodent infection models.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内